126 related articles for article (PubMed ID: 38382077)
1. Cutaneous Squamous Cell Carcinoma Outcomes in Solid Organ Transplant Recipients: A Matched Retrospective Cohort Study.
Walker TD; Liao YT; Nikahd M; Hyer M; Shahwan KT; Carr DR
Dermatol Surg; 2024 May; 50(5):412-417. PubMed ID: 38382077
[TBL] [Abstract][Full Text] [Related]
2. Melanoma Risk and Survival among Organ Transplant Recipients.
Robbins HA; Clarke CA; Arron ST; Tatalovich Z; Kahn AR; Hernandez BY; Paddock L; Yanik EL; Lynch CF; Kasiske BL; Snyder J; Engels EA
J Invest Dermatol; 2015 Nov; 135(11):2657-2665. PubMed ID: 26270022
[TBL] [Abstract][Full Text] [Related]
3. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
5. Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
Ritter A; Badir S; Mansour M; Segal Z; Ad-El D; Bachar G; Shpitzer T; Popovtzer A; Mizrachi A
Head Neck; 2021 Mar; 43(3):884-894. PubMed ID: 33247523
[TBL] [Abstract][Full Text] [Related]
6. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Head and Neck Microvascular Free Tissue Transfer for Advanced Cutaneous Squamous Cell Carcinoma: A Comparison of Solid Organ Transplant Recipients to Nontransplant Patients.
Wang RY; Gallagher KK; Hernandez DJ; Sandulache VC; Sturgis EM; Huang AT
J Oral Maxillofac Surg; 2024 Mar; 82(3):347-355. PubMed ID: 38103578
[TBL] [Abstract][Full Text] [Related]
8. Solid Organ Transplantation and Survival among Individuals with a History of Cancer.
Engels EA; Haber G; Hart A; Lynch CF; Li J; Pawlish KS; Qiao B; Yu KJ; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1312-1319. PubMed ID: 33926864
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
10. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
11. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
[TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell carcinoma in solid organ transplant recipients.
Fernández-Carrera González I; Ibarra Estupiñan C; Rivero Fernández I; Sanz Rodríguez M; García González E; Almodóvar Álvarez C; Gavilanes-Plasencia J
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):211-218. PubMed ID: 32562028
[TBL] [Abstract][Full Text] [Related]
13. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
[TBL] [Abstract][Full Text] [Related]
14. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
Tsung I; Worden FP; Fontana RJ
Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
[TBL] [Abstract][Full Text] [Related]
16. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tam S; Yao CMKL; Amit M; Gajera M; Luo X; Treistman R; Khanna A; Aashiq M; Nagarajan P; Bell D; El-Naggar A; Migden M; Wong M; Glisson B; Ferrarotto R; Esmaeli B; Rosenthal D; Li G; Weber RS; Myers JN; Gross ND
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):128-135. PubMed ID: 31804658
[TBL] [Abstract][Full Text] [Related]
17. Degree of differentiation of cutaneous squamous cell carcinoma: a comparison between a Swedish cohort of organ transplant recipients and immunocompetent patients.
Stenman C; Gonzalez H; Gillstedt M; Dellgren G; Hasséus B; Holmberg E; Rexius H; Öhman J; Paoli J
Dermatol Pract Concept; 2018 Oct; 8(4):330-336. PubMed ID: 30479868
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
19. Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients.
Ilyas M; Zhang N; Sharma A
Dermatol Surg; 2018 Mar; 44(3):370-374. PubMed ID: 29517497
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
